Medmira Inc. Stock
Price
Target price
?
?
0.000%
-
0.000%
-
07:35 / Stuttgart Stock Exchange
WKN: 932414 / Name: MedMira / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Medmira Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medmira Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medmira Inc. | 0.000% | -6.000% | 11.905% | 5.618% | -41.250% | -11.321% | - |
| Theralase Technologies Inc | -3.570% | -2.778% | 7.143% | -4.545% | -34.375% | -37.500% | 46.853% |
| Atossa Genetics Inc | -2.200% | -4.846% | 20.167% | -35.038% | -10.559% | 5.327% | -47.075% |
| Aortech International plc | - | -6.452% | -2.247% | -43.506% | -22.321% | -77.577% | -94.563% |
News
Health Canada approves MedMira’s Reveal® Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal®
MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 7, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate